Matthias Szabolcs

Professor
Pathology and Cell Biology
Columbia University Medical Center
United States of America

Professor Pathology
Biography

Matthias Szabolcs Professor of Clinical Pathology

Research Intrest

Dissection of molecular signaling pathways using genetically engineered mouse models

List of Publications
"Lau YK, Du X, Rayannavar V, Hopkins B, Shaw, JBessler et al.(2014) Metformin and erlotinib synergize to inhibit basal breast cancer. Oncotarget. 5 :10503-17. "
"Lau YK, Du X, Rayannavar V, Hopkins B, Shaw, JBessler et al.(2014) Metformin and erlotinib synergize to inhibit basal breast cancer. Oncotarget. 5 :10503-17. "
Stratikopoulos EE, Dendy M, Szabolcs M, Khaykin AJ, Lefebvre C et al (2015) Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy. Cancer Cell 27 : 837-51
Reczek CR, Shakya R, Miteva Y, Szabolcs M, Ludwig et al ( 2016) The DNA resection protein CtIP promotes mammary tumorigenesis. Oncotarget. 7 : 32172-83